Biden Says US Ready To Share COVID-19 Vaccine Related Technology - AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

President Joe Biden said that the U.S. will share technologies used to make COVID-19 vaccines through the World Health Organization and is working on expanding rapid testing and antiviral treatments for hard-to-reach populations.
"We are making available health technologies that are owned by the United States government, including stabilized spike protein that is used in many COVID-19 vaccines," Biden said in his opening speech.
It has gathered more than $3 billion in new funding to fight the pandemic, the White House said, including over $2 billion for immediate response and $962 million in commitments to the World Bank pandemic preparedness fund.
Biden has asked Congress for over $22.5 billion in additional COVID-19 response funds, including $5 billion for international aid. Lawmakers have failed to pass any funding bill, and those negotiating the package have been unable to agree on how to pay for the global response.
The U.S. National Institutes will license the technologies for Health to the WHO's COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP).
Scientists at the NIH worked with Moderna Inc MRNA to develop its COVID-19 shot.